Switching from current factor VIII (FVIII) to longer acting FVIII concentrates - what is the real potential benefit?

被引：8
作者：
Carcao, M. [1 ,2 ]
机构：
[1] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada
来源：
HAEMOPHILIA | 2015年 / 21卷 / 03期
关键词：
RECOMBINANT FACTOR-VIII; FC FUSION PROTEIN;
D O I：
10.1111/hae.12671
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：297 / 299
页数：3
相关论文
共 7 条
[1]   Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight [J].
Bjorkman, Sven ;
Oh, MyungShin ;
Spotts, Gerald ;
Schroth, Phillip ;
Fritsch, Sandor ;
Ewenstein, Bruce M. ;
Casey, Kathleen ;
Fischer, Kathelijn ;
Blanchette, Victor S. ;
Collins, Peter W. .
BLOOD, 2012, 119 (02) :612-618
[2]   Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A [J].
Collins, P. W. ;
Blanchette, V. S. ;
Fischer, K. ;
Bjorkman, S. ;
Oh, M. ;
Fritsch, S. ;
Schroth, P. ;
Spotts, G. ;
Astermark, J. ;
Ewenstein, B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (03) :413-420
[3]   Recombinant full-length factor VIII (FVIII) and extended half-life FVIII products in prophylaxis - new insight provided by pharmacokinetic modelling [J].
Gringeri, A. ;
Wolfsegger, M. ;
Steinitz, K. N. ;
Reininger, A. J. .
HAEMOPHILIA, 2015, 21 (03) :300-306
[4]   Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A [J].
Mahlangu, Johnny ;
Powell, Jerry S. ;
Ragni, Margaret V. ;
Chowdary, Pratima ;
Josephson, Neil C. ;
Pabinger, Ingrid ;
Hanabusa, Hideji ;
Gupta, Naresh ;
Kulkarni, Roshni ;
Fogarty, Patrick ;
Perry, David ;
Shapiro, Amy ;
Pasi, K. John ;
Apte, Shashikant ;
Nestorov, Ivan ;
Jiang, Haiyan ;
Li, Shuanglian ;
Neelakantan, Srividya ;
Cristiano, Lynda M. ;
Goyal, Jaya ;
Sommer, Jurg M. ;
Dumont, Jennifer A. ;
Dodd, Nigel ;
Nugent, Karen ;
Vigliani, Gloria ;
Luk, Alvin ;
Brennan, Aoife ;
Pierce, Glenn F. .
BLOOD, 2014, 123 (03) :317-325
[5]  
Neelakantan S, 2013, J THROMB HAEMOST, V11, P354
[6]   Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients [J].
Powell, Jerry S. ;
Josephson, Neil C. ;
Quon, Doris ;
Ragni, Margaret V. ;
Cheng, Gregory ;
Li, Ella ;
Jiang, Haiyan ;
Li, Lian ;
Dumont, Jennifer A. ;
Goyal, Jaya ;
Zhang, Xin ;
Sommer, Jurg ;
McCue, Justin ;
Barbetti, Margaret ;
Luk, Alvin ;
Pierce, Glenn F. .
BLOOD, 2012, 119 (13) :3031-3037
[7]   Multicentre, randomized, open-label study of on-demand treatment with two prophylaxis regimens of recombinant coagulation factor IX in haemophilia B subjects [J].
Valentino, L. A. ;
Rusen, L. ;
Elezovic, I. ;
Smith, L. M. ;
Korth-Bradley, J. M. ;
Rendo, P. .
HAEMOPHILIA, 2014, 20 (03) :398-406
1